Jane Street’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Jane Street’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,924	Closed	-$478K	–	6211
2018 Q3	$478K	Buy	+26,924	New	+$462K	﹤0.01%	3677
2014 Q3	–	Sell	-11,692	Closed	-$77K	–	3322
2014 Q2	$77K	Sell	11,692 -26,530	-69%	-$299K	﹤0.01%	2392
2014 Q1	$910K	Buy	+38,222	New	+$554K	0.01%	1039

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Jane Street's ECYT Position: Q4 2018 in Review

Jane Street sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 26,924 shares — an estimated $478K sold.

Jane Street first reported a position in ECYT in Q1 2014 and held it in 3 quarters. The position peaked at $910K in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Jane Street reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Jane Street sold 26,924 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $478K.
Jane Street first reported a position in Endocyte, Inc. Common Stock in Q1 2014 and held it in 3 quarters.
Jane Street's Endocyte, Inc. Common Stock position peaked at $910K in Q1 2014.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Jane Street's 13F filing for Q4 2018, filed 15 Feb 2019.